Abstract:You have accessJournal of UrologyProstate Cancer: Staging II (PD57)1 Apr 2020PD57-07 RADIOMIC SIGNATURE FROM BIPARAMETRIC MR IMAGES TO PREDICT BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY Ye Yan*, Lizhi Shao, Haizhui Xia, Wei He, Yuting Zhang, Zhenyu Liu, Jie Tian, and Jian Lu Ye Yan*Ye Yan* More articles by this author , Lizhi ShaoLizhi Shao More articles by this author , Haizhui XiaHaizhui Xia More articles by this author , Wei HeWei He More articles by this author , Yuting ZhangYuting Zhang More articles by this author , Zhenyu LiuZhenyu Liu More articles by this author , Jie TianJie Tian More articles by this author , and Jian LuJian Lu More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000967.07AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Of all patients who receiving radical prostatectomy, 15∼35% will develop biochemical recurrence (BCR) from 3 to 10 years after surgery. We are aiming at assessing the efficacy of radiomic features acquired from pre-surgery biparametric MRI to predict biochemical recurrence after radical prostatectomy. METHODS: 278 patients in one center from 2010 to 2016 were enrolled. All the patients were randomly divided into training (223 cases, 80%) and validating (55 cases, 20%) cohorts. Data in Dicom format from T2TSE sequences and apparent diffusion coefficient (ADC) maps was collected. Tumoral region of interests (ROIs) were segmented on each slice which were based on actual computational pathological slices for each level. Radiomic features including texture, shape, intensity and wavelet were extracted from ROIs. Adaptive elastic net was performed for feature selection. Cox proportional hazards regression was used to create a BCR-free survival model with selected radiomic features. A radiomic nomogram with clinical parameters incorporated were established for individualized BCR-free survival estimation. RESULTS: 13 radiomic features were selected to generate a radiomic signature. Significant differences were found between the high- and low-radiomic score patients in BCR-free survival in both training and validating cohorts (p<0.01). Radiomic based BCR-free survival model achieved C-index of 0.710 in the training cohort and 0.703 in the validating cohort, respectively, which performed better than NCCN risk stratification model. A clinicopathological predictive model consisted of total PSA, pathological T stage, ISUP grade group and surgical margin were established with C-index of 0.669 in training cohort and 0.566 in validating cohort for BCR-free survival prediction. However, combing radiomic signature with clinicopathological parameters model yielded C-index of 0.661 in training cohort and 0.628 in validating cohort, which did not significantly outperform pure radiomic model. A nomogram based on radiomic signature was generated for 1- to 5-year BCR probability estimation personally. CONCLUSIONS: The newly developed radiomic model is a powerful predictor of BCR-free survival for patients with radical prostatectomy. Source of Funding: none © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1196-e1196 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Ye Yan* More articles by this author Lizhi Shao More articles by this author Haizhui Xia More articles by this author Wei He More articles by this author Yuting Zhang More articles by this author Zhenyu Liu More articles by this author Jie Tian More articles by this author Jian Lu More articles by this author Expand All Advertisement PDF downloadLoading ...

MP62-06 COMBINED CLINICAL CHARACTERISTICS AND MULTIPARAMETRIC MRI PARAMETERS FOR PREDICTION OF CRIBRIFORM MORPHOLOGY IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS

Combined Clinical Characteristics and Multiparametric MRI Parameters for Prediction of Cribriform Morphology in Intermediate-Risk Prostate Cancer Patients.

Diagnostic Performance of a Nomogram Incorporating Cribriform Morphology for the Prediction of Adverse Pathology in Prostate Cancer at Radical Prostatectomy

MP49-02 DEVELOPMENT AND EXTERNAL VALIDATION OF INTERPRETABLE MACHINE LEARNING MODELS FOR CLINICALLY SIGNIFICANT PROSTATE CANCER DIAGNOSIS IN PATIENTS WITH LESIONS OF PI-RADS V2.1 SCORE ≥3

MP16-15 THE DIAGNOSTIC ROLE OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BEFORE INITIAL PROSTATE BIOPSY: THE DEVELOPMENT OF NOMOGRAMS PREDICTING THE OUTCOMES OF PROSTATE BIOPSY

PD43-04 COMBINATION OF VERSION 2.0 PROSTATE IMAGING REPORTING AND DATA SYSTEM (PI-RADS) AND PERIPROSTATIC FAT THICKNESS ON MULTIPARAMETRIC MRI TO PREDICT THE PRESENCE OF PROSTATE CANCER

Development and External Multicenter Validation of Chinese Prostate Cancer Consortium Prostate Cancer Risk Calculator for Initial Prostate Biopsy.

Preoperative Multiparametric Magnetic Resonance Imaging Based Risk Stratification System for Predicting Biochemical Recurrence After Radical Prostatectomy

Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions

Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort

PD57-07 RADIOMIC SIGNATURE FROM BIPARAMETRIC MR IMAGES TO PREDICT BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY

Utility of Clinical-Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions

Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL

Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making

A novel, AI-generated morphologic biomarker to predict prostate cancer recurrence in patients with intermediate risk of progression.

The Role of Multiparametric MRI (mpMRI) in the Prediction of Adverse Prostate Cancer Pathology in Radical Prostatectomy Specimen

PI-RADS Score of Prostate Multi-Parametric Magnetic Resonance Imaging Predicts Pathological Features of Prostate Cancer:An Imaging to Whole-Mount Pathology Matching Study

Integration of Multiparameter MRI into Conventional Pretreatment Risk Factors to Predict Positive Surgical Margins after Radical Prostatectomy.

Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot‐assisted radical prostatectomy

Added Value of Biparametric MRI and TRUS-Guided Systematic Biopsies to Clinical Parameters in Predicting Adverse Pathology in Prostate Cancer

Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low- intermediate risk prostate cancer patients